Portal de Periódicos da CAPES

Letters to the Editor

1998; Wiley; Volume: 13; Issue: 3 Linguagem: Inglês

10.1002/mds.870130351

1531-8257

Tetsuo Sakai, Jolyon Meara, Peter Hobson,

Restless Legs Syndrome Research

Movement DisordersVolume 13, Issue 3 p. 622-622 Letters to the Editor Letters to the Editor Tetsuo Sakai MD, PhD, Tetsuo Sakai MD, PhD Department of Neurology, National Chikugo Hospital, JapanSearch for more papers by this authorJolyon Meara MD, Jolyon Meara MD University Department of Geriatric Medicine, Glan Clwyd Hospital, North WalesSearch for more papers by this authorPeter Hobson BSc, Peter Hobson BSc University Department of Geriatric Medicine, Glan Clwyd Hospital, North WalesSearch for more papers by this author Tetsuo Sakai MD, PhD, Tetsuo Sakai MD, PhD Department of Neurology, National Chikugo Hospital, JapanSearch for more papers by this authorJolyon Meara MD, Jolyon Meara MD University Department of Geriatric Medicine, Glan Clwyd Hospital, North WalesSearch for more papers by this authorPeter Hobson BSc, Peter Hobson BSc University Department of Geriatric Medicine, Glan Clwyd Hospital, North WalesSearch for more papers by this author First published: 04 November 2004 https://doi.org/10.1002/mds.870130351Citations: 6Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1 Friedmann JH. Machado-Joseph disease/spinocerebellar ataxia 3 responsive to buspirone. Mov Disord 1997; 12: 613–614. 10.1002/mds.870120426 Web of Science®Google Scholar 2 Mello KA, Abbott BP. Effect of sulfamethoxazole and trimethoprim on neurologic dysfunction in a patient with Joseph's disease. Arch Neurol 1988; 45: 210–213. 10.1001/archneur.1988.00520260098028 CASPubMedWeb of Science®Google Scholar 3 Sakai T, Matsuishi T, Yamada S, Komori H, Iwashita H. Sulfamethoxazole-trimethoprim double-blind, placebo-controlled, crossover trial in Machado-Joseph disease: sulfamethoxazole-trimethoprim increases cerebrospinal fluid level of biopterin. J Neural Transm (Gen Sect) 1995; 102: 159–172. 10.1007/BF01276511 CASPubMedWeb of Science®Google Scholar 4 Sakai T, Antoku Y, Matsuishi T, Iwashita H. Tetrahydrobiopterin double-blind, crossover trial in Machado-Joseph disease. J Neurol Sci 1996; 136: 71–72. 10.1016/0022-510X(95)00296-E CASPubMedWeb of Science®Google Scholar References 1 Hauser RA, Zesiewicz TA. Sertraline for the treatment of depression in Parkinson's disease. Mov Disord 1997; 12: 756–759. 10.1002/mds.870120522 CASPubMedWeb of Science®Google Scholar 2 Meara RJ, Bhowmick BK, Hobson JP. An open uncontrolled study of the use of sertraline in the treatment of depression in Parkinson's disease. Journal of Serotonin Research 1996; 4: 243–249. Google Scholar 3 Yesevage JA, Brink TL. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 1983; 17: 37–49. Google Scholar 4 Meara RJ, Mitchelmore E, Hobson JP. Use of the GDS-15 as a screening instrument for depressive symptomatology in patients with Parkinson's disease and their carers in the community. Age Ageing. In press. Google Scholar 5 Miller E, Berrios GE, Politynska BE. Caring for someone with Parkinson's disease: factors that contribute to distress. International Journal of Geriatric Psychiatry 1996; 11: 263–268. 10.1002/(SICI)1099-1166(199603)11:3 3.0.CO;2-P Web of Science®Google Scholar Citing Literature Volume13, Issue3May 1998Pages 622-622 ReferencesRelatedInformation